MBC BioLabs, which has locations in the heart of San Francisco’s thriving biotech community, provides a supportive and collaborative environment for biotech startups to grow and flourish. The addition of Abberior's STEDYCON is a major investment in the future of biotech innovation and will help to further position MBC BioLabs as a leading destination for life science entrepreneurs.
"We are committed to providing our members with the resources and support they need to succeed, and the installation of Abberior's STED microscope is a major step forward in that effort," said Dr. Doug Crawford, Founder of MBC BioLabs. "This tool will play a critical role in helping our startups to develop innovative products and therapies that will have a transformative impact on human health and well-being."About Abberior
Abberior is a leading provider of cutting-edge imaging technologies, including super-resolution STED microscopy systems, MINFLUX nanoscopy systems, and fluorescence probes. The company's products are used by researchers and life science professionals around the world to gain new insights into biological structures and processes at the nanoscale level. Visit: https://abberior.rocks/
.About MBC BioLabs
MBC BioLabs is dedicated to helping life-science startups succeed. By renting space as small as a single lab bench and providing these entrepreneurial scientists with access to millions of dollars of equipment, MBC BioLabs allows companies to be fast, focused, and frugal. It has three sites: one in the Dogpatch neighborhood in San Francisco and two campuses in San Carlos, California. Each site has a complete molecular biology core facility that allows companies to do experiments on day one. MBC BioLabs has partnerships with leading pharmaceutical and life-science companies as well as a built-in venture capital firm, Mission BioCapital. These partnerships provide entrepreneurs with valuable insights about where to focus their efforts and accelerates the innovation pipeline. Since opening in 2013, MBC BioLabs has helped launch and grow 290 companies. These companies have brought 153 programs into the clinic, produced 13 approved diagnostics, and raised over $13 billion. Visit: www.mbcbiolabs.com